Li Rongjie to lose control of Fengyuan Pharmaceutical, Fengyuan Group no longer holds any A-share listed company

Corporate Action
โดย 皖西学院官网·Read original
Summary · why it matters

Fengyuan Pharmaceutical announced that three concert parties under its controlling shareholder Fengyuan Group plan to transfer their equity to Bengbu Investment Group. After the transaction, the controlling shareholder will change to Bengbu Investment Group, the actual controller will change from Li Rongjie to the Bengbu Municipal State-owned Assets Supervision and Administration Commission, and Fengyuan Group and its concert parties will no longer hold any shares in Fengyuan Pharmaceutical. Li Rongjie took over Bengbu Citric Acid Plant in 1994 and built the Fengyuan Group, which once owned three A-share listed companies: Fengyuan Biochemical, Fengyuan Pharmaceutical, and ST Taifu. However, Fengyuan Biochemical changed hands to COFCO Group in 2006, and control of ST Taifu fell to Shandong state-owned capital in 2012. With this transfer of control over Fengyuan Pharmaceutical, the Fengyuan Group will no longer have any actual controlling stake in an A-share listed company. Zhang Jun, board secretary of Fengyuan Pharmaceutical, said the matter is still in the planning stage and information is limited to the announcement. As of June 16, 2026, Fengyuan Group's total outstanding borrowings of various types amounted to approximately 11.5 billion yuan, with about 1.5 billion yuan due for repayment in the coming year, while net profit in the first quarter of 2026 was only 134 million yuan, indicating significant debt pressure.

Impact on stocks 2

Others▼ · 2 stocks

Off-coverage companies 2

安徽丰原集团有限公司Private▼ Negative
Capitalrelevance

Fengyuan Group losing control of last A-share listed company and facing 11.5 billion yuan debt with only 134 million yuan quarterly net profit.

蚌埠投资集团有限公司Private± Mixed
relevance

© 2026 MarketDXNews